title: [Safety aspect of age macular degeneration treatment].
authors.forename: S K
authors.initials: SK
authors.lastname: Zyrianov
authors.forename: Iu B
authors.initials: IuB
authors.lastname: Belousov
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D056965:Injections, Intraocular; D008268:Macular Degeneration / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D056687:Off-Label Use / Q000145:classification / Q000941:ethics; D061214:Patient Safety / Q000592:standards*; D011364:Professional Practice / Q000941:ethics / Q000592:standards; D012160:Retina / Q000187:drug effects*; D013923:Thromboembolism / Q000139:chemically induced; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A